|LETTER TO THE EDITOR
|Year : 2014 | Volume
| Issue : 2 | Page : 85
Screening for thyroid dysfunction during pregnancy
Mohammed El Amine Amani1, Farida Chentli2
1 Department of Endocrine and Diabetes, 1st November 1954 University Hospital, Oran, Algeria
2 Department of Endocrine and Metabolic Diseases, Bab El Oued Hospital, Algiers, Algeria
|Date of Web Publication||31-Mar-2014|
Mohammed El Amine Amani
1st November 1954 University Hospital, BP No 4166 Ibn Rochd, Oran
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Amani ME, Chentli F. Screening for thyroid dysfunction during pregnancy. Thyroid Res Pract 2014;11:85
We read with great interest of your article entitled "Screening for thyroid dysfunction during pregnancy" by Shah, et al.,  the issue of May-August 2013. We would like to make our contribution in the light of our modest experience.
It is now well established that any thyroid abnormality in the mother may be harmful for both the course of the pregnancy and the somatic and neurological development of the fetus.
As reported by Shah et al.,  many societies do not recommend universal screening of the thyroid dysfunctions during pregnancy, except in pregnant women with risk factors. Shah et al.,  found that 92% of hypothyroid pregnant women and 87.5% of hyperthyroid ones had no risk factors. Otherwise, many studies around the world, as reported by the author, showed that the percentage of dysthyroid women with no risk factor were about 30-80% for hypothyroidism and 80-88% for hyperthyroidism. ,,, These results interpel us when we know the terrible consequences of thyroid dysfunction as reported above. These findings led Shah et al.,  to recommend universal screening of thyroid abnormalities in the preconception or in early pregnancy with a measurement of TSH, attitude that we adhere completely because TSH assay is simple, reliable, available, and low cost, also in order not to omit dysthyroid pregnant women and leave them without treatment, therefore, being exposed to complications.
| References|| |
|1.||Shah JM, Mehta MN, Viradia HB. Screening for thyroid dysfunction during pregnancy. Thyroid Res Pract 2013;10:65-7. |
|2.||Chang DL, Leung AM, Braverman LE, Pearce EN. Thyroid testing during pregnancy at an academic Boston Area Medical Center. J Clin Endocrinol Metab 2011;96:E1452-6. |
|3.||Horacek J, Spitalnikova S, Dlabalova B, Malirova E, Vizda J, Svilias I, et al. Universal screening detects two-times more thyroid disorders in early pregnancy than targeted high-risk case finding. Eur J Endocrinol 2010;163:645-50. |
|4.||Wang W, Teng W, Shan Z, Wang S, Li J, Zhu L, et al. The prevalence of thyroid disorders during early pregnancy in China: The benefits of universal screening in the first trimester of pregnancy. Eur J Endocrinol 2011;164:263-8. |
|5.||Dosiou C, Sanders GD, Araki SS, Crapo LM. Screening pregnant women for autoimmune thyroid disease: A cost-effectiveness analysis. Eur J Endocrinol 2008;158:841-51. |